title: Does Paricalcitol (Zemplar®) interfere with 1,25-dihydroxyvitamin D measurement by liquid chromatography-tandem mass spectrometry assays?
authors.forename: Joe M
authors.initials: JM
authors.lastname: El-Khoury
authors.forename: Fuat
authors.initials: F
authors.lastname: Bicer
authors.forename: Dustin R
authors.initials: DR
authors.lastname: Bunch
authors.forename: Chao
authors.initials: C
authors.lastname: Yuan
authors.forename: Sihe
authors.initials: S
authors.lastname: Wang
mesh_terms: D016477:Artifacts; D050071:Bone Density Conservation Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002853:Chromatography, Liquid / Q000592:standards; D004872:Ergocalciferols / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000517:prevention & control; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry / Q000592:standards; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D050071:Bone Density Conservation Agents; D004872:Ergocalciferols; D014807:Vitamin D; C097949:1,25-dihydroxyvitamin D; C084656:paricalcitol